Status:
RECRUITING
Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborating Sponsors:
Université de Montréal
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
High Risk Pregnancy
Arterial Stiffness
Eligibility:
FEMALE
18+ years
Brief Summary
Despite advances in obstetric care, preeclampsia (PE) remains the leading cause of maternal death and disability in both developed and developing countries, contributing to over 70,000 maternal and 50...
Detailed Description
Existing predictive tools for preeclampsia (PE), including clinical characteristics, blood pressure, blood biomarkers, and uterine artery Doppler indices, have, at best, moderate predictive properties...
Eligibility Criteria
Inclusion
- Singleton pregnancy
- Presence of at least 1 high-risk factor or 2 moderate-risk factors for pre-eclampsia
Exclusion
- \>14 weeks gestation
- Multiple pregnancy
- History of heart disease, stroke, or peripheral arterial disease
- Infectious diseases/conditions, such as Hepatitis B/C, HIV, and COVID19
Key Trial Info
Start Date :
July 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT04783597
Start Date
July 12 2021
End Date
January 1 2027
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Victoria Hospital
Montreal, Quebec, Canada, H3A 1A1